Association of Survival With Chemoendocrine Therapy in Women With Small, Hormone Receptor-Positive, ERBB2-Positive, Node-Negative Breast Cancer.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 32271387.
- Also identified by DOI 10.1001/jamanetworkopen.2020.2507 and PMC identifier 7146098.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study examines the association of survival with adjuvant chemoendocrine therapy for hormone receptor–positive, ERBB2-positive, node-negative breast cancer.
Medical subject headings
- Antineoplastic Agents, Hormonal
- Breast Neoplasms